{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:47:06Z","timestamp":1758268026518,"version":"3.44.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Phramongkutklao Hospital Foundation"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>Obesity is related to a dysregulation in circulating adipokines and might have a potential role in the pathogenesis of systemic lupus erythematosus (SLE). This study aimed to determine the association between serum leptin levels, body mass index (BMI), and disease activity in women with SLE. Female SLE patients were included in the study. Demographic data, clinical manifestations, comorbidities, and serum leptin levels were collected at baseline. The weight statuses were defined as; normal: BMI 18.5 to 24.9 kg\/m<jats:sup>2<\/jats:sup>; overweight: BMI 25 to 29.9 kg\/m<jats:sup>2<\/jats:sup>; and obese: BMI\u2005\u2265\u200530 kg\/m<jats:sup>2<\/jats:sup>. The SLE Disease Activity Index 2000 (cSLEDAI-2K) in clinical domains, Systemic Lupus International Collaborating Clinic\/American College of Rheumatology Damage Index and BMI were reviewed over the 1-year prior to enrollment. BMI, serum leptin levels and disease activity were examined for their association using multivariate regression analyses. Of 221 SLE patients, 23 patients (10.41%) were obese, 51 patients (23.08%) were overweight, and 147 patients (66.52%) were normal. Obese patients were found to have more hypertension, dyslipidemia, diabetes, and lower glomerular filtration rate than other categories. Moreover, BMI was correlated with an increase of cSLEDAI-2K over the past year (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.21, <jats:italic toggle=\"yes\">P<\/jats:italic> value\u2005=\u2005.002). Only 80 blood samples were tested for leptin levels. The correlations were found between increased leptin levels with neuropsychiatric manifestations (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.24, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.04), hematologic manifestations (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u2005\u22120.27, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.02), and BMI (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.69, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Patients with leptin level\u2005\u2265\u200520,676 pg\/mL had more increase of cSLEDAI-2K over the past year (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.03) than those with lower level. In multivariate analysis, neither BMI nor leptin had a significant association with cSLEDAI-2K. Approximately one-third of SLE patients in this study were overweight or obese, and this group had a higher prevalence of metabolic comorbidities. The study found a significant association between serum leptin levels and BMI. Although, BMI and leptin levels were not significantly associated with an increase of SLE disease activities due to limited population, the trend showed a positive correlation.<\/jats:p>","DOI":"10.1097\/md.0000000000043646","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:41Z","timestamp":1754089301000},"page":"e43646","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The association between serum leptin levels, body mass index, and disease activity in women with systemic lupus erythematosus"],"prefix":"10.1097","volume":"104","author":[{"given":"Nittayawadee","family":"Aeamsaard","sequence":"first","affiliation":[{"name":"Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumapa","family":"Chaiamnuay","sequence":"additional","affiliation":[{"name":"Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pongthorn","family":"Narongroeknawin","sequence":"additional","affiliation":[{"name":"Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paijit","family":"Asavatanabodee","sequence":"additional","affiliation":[{"name":"Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9228-5650","authenticated-orcid":false,"given":"Rattapol","family":"Pakchotanon","sequence":"additional","affiliation":[{"name":"Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/acr.20343","article-title":"Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus.","volume":"63","author":"Katz","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.semarthrit.2018.10.004","article-title":"A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among Black women.","volume":"48","author":"Cozier","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semarthrit.2017.05.011","article-title":"Obesity and the risk of systemic lupus erythematosus among women in the nurses\u2019 health studies.","volume":"47","author":"Tedeschi","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/RHU.0b013e3180645865","article-title":"The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].","volume":"13","author":"Chaiamnuay","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10067-018-4336-3","article-title":"The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR).","volume":"38","author":"Teh","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/art.21400","article-title":"Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus.","volume":"52","author":"Oeser","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/acr.23576","article-title":"Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus.","volume":"71","author":"Patterson","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/acr.20526","article-title":"Impact of obesity on functioning among women with systemic lupus erythematosus.","volume":"63","author":"Katz","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1756-185X.2011.01698.x","article-title":"The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.","volume":"15","author":"Rizk","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2006.059311","article-title":"African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV).","volume":"66","author":"Chaiamnuay","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R11-20250918","first-page":"389","article-title":"Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis.","volume":"36","author":"Mok","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"R12-20250918","first-page":"2551","article-title":"Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity.","volume":"29","author":"Bernatsky","year":"2002","journal-title":"J Rheumatol"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/acr.21587","article-title":"Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus.","volume":"64","author":"Katz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/0961203320913616","article-title":"Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus.","volume":"29","author":"Kang","year":"2020","journal-title":"Lupus"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity.","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/S0482-50042012000200011","article-title":"Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis.","volume":"52","author":"Barbosa","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clim.2013.09.002","article-title":"Leptin promotes lupus T-cell autoimmunity.","volume":"149","author":"Amarilyo","year":"2013","journal-title":"Clin Immunol"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0961203317725587","article-title":"Association between circulating leptin levels and systemic lupus erythematosus: an updated meta-analysis.","volume":"27","author":"Lee","year":"2018","journal-title":"Lupus"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3899\/jrheum.080503","article-title":"Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors.","volume":"36","author":"Vadacca","year":"2009","journal-title":"J Rheumatol"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.","volume":"70","author":"McMahon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11739-011-0726-0","article-title":"Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus.","volume":"8","author":"Vadacca","year":"2013","journal-title":"Intern Emerg Med"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203316646463","article-title":"Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.","volume":"26","author":"Santos","year":"2017","journal-title":"Lupus"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00296-017-3924-x","article-title":"Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.","volume":"38","author":"Mahieu","year":"2018","journal-title":"Rheumatol Int"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00296-008-0526-7","article-title":"Serum leptin in systemic lupus erythematosus.","volume":"28","author":"Wislowska","year":"2008","journal-title":"Rheumatol Int"},{"key":"R25-20250918","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R26-20250918","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R27-20250918","first-page":"1","article-title":"Report of a WHO consultation.","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R29-20250918","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000.","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"R30-20250918","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus.","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R31-20250918","first-page":"1977","article-title":"Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.","volume":"30","author":"Ibanez","year":"2003","journal-title":"J Rheumatol"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.","volume":"355","author":"Adams","year":"2006","journal-title":"N Engl J Med"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans.","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"R36-20250918","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1073\/pnas.1607101113","article-title":"Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.","volume":"113","author":"Lourenco","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-20250918","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications.","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"R38-20250918","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNR.0000000000000546","article-title":"The role of leptin in central nervous system diseases.","volume":"27","author":"Li","year":"2016","journal-title":"Neuroreport"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:56Z","timestamp":1758232916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":35,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043646","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}